Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE StudyHoward S. Höchster, Eric Hedrick, Lucas Wong et al.|Journal of Clinical Oncology|2008Cited by 623
Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.George Yaghmour, Michael G. Martin, Manjari Pandey et al.|PubMed|2016Cited by 29
Role of genomic instability in immunotherapy with checkpoint inhibitors.George Yaghmour, Michael G. Martin, Lee S. Schwartzberg et al.|Journal of Clinical Oncology|2016Cited by 16